| Serial Number | 99729374 |
| Word Mark | ZELRISTY |
| Filing Date | Friday, March 27, 2026 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Tuesday, July 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical and biological preparations based on base editing, base modification, nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene therapy, genome editing, genome modification, cell therapy, cellular modification, and tissue modification for use in human therapeutics for the treatment of Sickle Cell Disease |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 27, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Beam Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 US |
| Event Date | Event Description |
| Friday, March 27, 2026 | NEW APPLICATION ENTERED |
| Friday, March 27, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 27, 2026 | APPLICATION FILING RECEIPT MAILED |
| Friday, June 26, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, July 14, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |